Series B - Dermira
Investment Firm
Overview
Dermira is a development-stage biotech company focused on developing and commercializing innovative new therapies in dermatology.
Announced Date
Jun 11, 2013
Funding Type
Series B
Highlights
Location
United States, North America
Social
Investor Lead
Participant Investors
4
Round Details and Background
Dermira raised $35000000 on 2013-06-11 in Series B
Dermira is a development-stage biotech company focused on developing and commercializing innovative new therapies in dermatology.
Company Funding History
13
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Sep 12, 2016 |  Post-IPO Equity - Dermira | - | 1.5M | |
| Aug 19, 2014 | Series C - Dermira | 8 | - | 51.0M |
| Jun 11, 2013 | Series B - Dermira | 4 | - | 35.0M |
| Oct 20, 2011 | Series A - Dermira | 3 | - | 42.0M |
Recent Activity
There is no recent news or activity for this profile.